DB
Darrell Borne
EVP, CFO, Secretary/Treasurer

Darrell Borne insider trades: Sciele Pharma (SCRX) stock sales

EVP, CFO, Secretary/Treasurer, Sciele Pharma Last trade Jan 24, 2008 11 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2006
2
Companies
last trade 2008

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Darrell reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jan 24, 2008SCRX↓ Sell10b5-1$278K
Dec 7, 2007SCRX↓ Sell10b5-1$341K
Oct 31, 2007SCRX↓ Sell10b5-1$1.5M
Jan 29, 2007SCRX↓ Sell10b5-1$721K
Jan 24, 2007SCRX↓ Sell10b5-1$209K
Nov 1, 2006SCRX↓ Sell10b5-1$814K
May 16, 2006FHRX↓ Sell10b5-1$1.1M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Darrell Borne's insider trades

Darrell Borne is EVP, CFO, Secretary/Treasurer at Sciele Pharma (SCRX). Since May 16, 2006, Darrell has reported no open-market purchases and 7 sales worth $4.9M on SEC Form 4. There have been no open-market trades in the last 12 months.

7 sales (100% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include grants and awards (4 filings), option exercises (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SCRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.